The mifepristone and misoprostol (MS-2 Step®) web outcome has been updated with the PBAC’s recommendation that authorised midwives be included as an eligible PBS prescriber type for this listing, in addition to medical practitioners and nurse practitioners.

Details of the PBAC’s recommendation can be found on the ‘Recommendations made out-of-session by the PBAC between meetings’ webpage under ‘Recommendations made out-of-session by the Pharmaceutical Benefits Advisory Committee (PBAC) between its March 2023 and July 2023 meetings’.